Best Semaglutide Providers at 1mg in 2026: Ranked and Reviewed
One filter builds this table: the seller publishes a semaglutide price at 1mg. Sellers who stock other tiers and skip this one drop out, which is why the list runs shorter than the full semaglutide board. Each row carries the therapeutic dose figure a seller advertises, the date we last checked it, and our independent score. Whether 1mg is the right tier for you is a call for your prescriber.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
1 semaglutide providers compared · independently scored against our six-factor methodology.
Methodology & sources
Each provider here carries a score from our published six-factor rubric[1], and the list is then cut down to the dose named in the page title.
Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[2]. The SURMOUNT-5 head-to-head published in 2025 directly compared tirzepatide and semaglutide[3].
The same filter is run at the other doses we rank: 0.25mg, 0.5mg, 1.7mg and 2.4mg, and brand-name semaglutide has its own ranking of brand sellers.
Quick Picks
| # | Provider | Score | |
|---|---|---|---|
| 1 | FormidableMD | Visit |
Detailed Reviews
FormidableMD
Best for: patients in four states who want visit-by-visit care with no membership
Pay as you go: $199 for the first consultation, $99 for each follow-up, and no membership or commitment behind either. Medication is priced by dose and paid separately, from $169 at the 1 mg semaglutide tier and $199 at the 10 mg tirzepatide tier. The practice is based in Saint Johns, Florida, and holds telehealth visits for four states: FL, GA, NJ and NY. It offers FDA-approved and compounded GLP-1s, compounded drugs come from 503A pharmacies, and visits qualify for FSA/HSA.
Score Breakdown
Frequently Asked Questions
Sources & methodology — as of November 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 3.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.